Newsfeeds - Spark Newswire

2 minute read

Short Volatility Alert: Eagle Pharmaceuticals, Inc.

Today, 10:30 PM

On Tuesday, shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) experienced volatile short activity. After the activity, the stock price went up +2.39% to $43.35. The overall sentiment for EGRX has been Bearish.

EGRX

16 minute read

Earnings Scheduled For May 9, 2022

By Benzinga Insights

Today, 10:30 PM

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

ACM

1 minute read

Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal

By Vandana Singh

Today, 10:30 PM

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has agreed to acquire Acacia Pharma Group plc

EGRX

1 minute read

Eagle Pharma’s Q4 Earnings Miss Street View On Lower Product Sales

By Vandana Singh

Today, 10:30 PM

Eagle Pharmaceuticals Inc’s (NASDAQ:EGRX) Q4 FY21 sales declined 15% Y/Y to $42.3 million, missing the consensus of $51.08 million. The…

EGRX

1 minute read

Eagle Pharmaceuticals: Q4 Earnings Insights

By Benzinga Insights

Today, 10:30 PM

Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q4 earnings results on Monday, March 7, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

EGRX

1 minute read

Eagle Pharmaceuticals Q4 EPS $0.85 Misses $0.94 Estimate, Sales $42.30M Miss $51.08M Estimate

By Benzinga Newsdesk

Today, 10:30 PM

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.94 by 9.57 percent. This is a 11.46 percent decrease over earnings of $0.96 per share

EGRX

3 minute read

Earnings Scheduled For March 7, 2022

By Benzinga Insights

Today, 10:30 PM

Companies Reporting Before The Bell • Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million.

AIRI

3 minute read

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg

By Shanthi Rexaline

Today, 10:30 PM

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.

ACHV

1 minute read

Earnings

Eagle Pharmaceuticals’s Earnings Outlook

By Benzinga Insights

Today, 10:30 PM

Eagle Pharmaceuticals (NASDAQ:EGRX) is set to give its latest quarterly earnings report on Monday, 2022-03-07. Here's what investors need to know before the announcement. Analysts estimate that Eagle Pharmaceuticals will report an earnings per share (EPS) of $0.94.

EGRX

2 minute read

Eagle Pharmaceuticals Announces Commercial Availability Of Vasopressin

By Bill Haddad

Today, 10:30 PM

-- Shipment of vasopressin, a generic alternative to Vasostrict®, commences today, with 180 days of marketing exclusivity -- -- Product launch expected to drive significant revenue growth in 2022 -- WOODCLIFF LAKE,

EGRX